Tag: Dermira
No posts to display
News
U.S. FDA approves subcutaneous administration of Takeda’s ENTYVIO for Crohn’s disease
The U.S. Food and Drug Administration (FDA) has approved Takeda's ENTYVIO (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely...
CARVYKTI becomes first BCMA-targeted treatment approved by European Commission for patients with relapsed and...
The European Commission (EC) has approved a Type II variation for Janssen-Cilag International NV's (a Johnson & Johnson company) CARVYKTI (ciltacabtagene autoleucel; cilta-cel).
This latest...
Evotec and Variant Bio to discover and develop fibrosis treatments
Evotec and Variant Bio have announced a collaboration agreement to identify a best-in-class treatment for diseases caused by fibrosis.
Fibrosis is characterised by marked and...
